Early Trial Results Show Potential for CAR T-Cell Therapy in Head and Neck Cancer – Targeted Oncology
Targeted Oncology |
Early Trial Results Show Potential for CAR T-Cell Therapy in Head and Neck Cancer
Targeted Oncology Beyond hematologic malignancies, chimeric antigen receptor (CAR) T-cell therapy could also potentially be effective in solid tumors, such as head and neck cancer, according to early results of a clinical trial presented at the 2017 AACR Annual Meeting. |
